These estrogen-related effects can amplify the activity of APOE. In fact, it is well-known that APOE-ε4 allele acts as a negative modulator of neuropsychiatric features in AD patients (Spalletta et al., 2006; Steinberg et al., 2006; Panza et al., 2012). Here, APOE is linked to Alzheimer disease.